This inventor holds 1 USPTO granted patent and 4 published patent applications. Top assignee: Janssen Pharmaceutica Nv. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Caroline Anne Aerts: Pharmaceutical Formulation Inventor.
Introduction
Caroline Anne Aerts is an inventor associated with Beerse, Belgium, and Janssen Pharmaceutica NV. Her patent work concerns esketamine formulations and methods for their preparation and storage.
Latest Patents
Aerts is credited with 1 patent: “Esketamine Formulations and Methods for Preparation and Storage.” The disclosure describes pharmaceutical compositions containing esketamine, or a pharmaceutically acceptable salt of esketamine, and an oxidative degradant. It identifies 6-(2-chlorophenyl)-6-oxohexanoic acid, or a pharmaceutically acceptable salt thereof, as one such degradant. The patent also describes methods for limiting the formation of oxidative degradants in esketamine compositions.
Career Highlights
Aerts’s listed patent reflects work on pharmaceutical formulation and stability, with a focus on managing oxidative degradation during the preparation and storage of esketamine products. Her company affiliation is Janssen Pharmaceutica NV.
Collaborations
The provided information lists Koen Maria Schrijnemakers and Kris Kayens as Aerts’s coworkers.
Conclusion
Caroline Anne Aerts’s patent contribution centers on esketamine formulation stability and methods intended to limit oxidative degradant formation.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile